Testosterone therapy for trans men: what TikTok gets right and wrong
Quick answer
The creator describes accessing testosterone-based hormone replacement therapy as a transgender man following an extensive evaluation period including psychotherapy and endocrinology consultation, consistent with WPATH SOC version 7 era clinical pathways. Current WPATH SOC8 guidelines (Coleman et al., 2022) have largely shifted toward informed consent models for adult patients, reducing but not eliminating clinical evaluation requirements. Testosterone therapy in transgender men requires baseline and ongoing monitoring of hematocrit, lipid panels, and hepatic function regardless of the access pathway used.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @andrisdehnke actually say?
@andrisdehnke shared a personal account of his transition timeline: he identified as transgender at 12, came out at 12, but couldn't access medical transition until 18. He says he had to complete therapy and see multiple doctors before meeting with an endocrinologist to receive hormones. His framing is that this process exists and is rigorous, pushing back against what he calls "false narratives."
This is largely a personal testimony, not a medical claim. He isn't prescribing anything or making specific physiological assertions. He's describing a gatekeeping process he experienced firsthand, which is worth evaluating against what the evidence and current clinical guidelines actually say about how gender-affirming hormone therapy (GAHT) is accessed in the United States.
Does the science back this up?
His description of the access process is broadly accurate for his era and location, though it's becoming less universal. Yes, historically, extensive gatekeeping was standard. Whether that's still required depends on where you live and who your provider is.
The World Professional Association for Transgender Health (WPATH) Standards of Care Version 8, published in 2022, moved away from mandatory therapy requirements before hormones. SOC8 now recommends an informed consent model in many cases, meaning a competent adult can access GAHT after a thorough informed consent discussion, without a mandatory mental health referral. Coleman et al. (2022, International Journal of Transgender Health) specifically removed the previous requirement for a mental health letter in most adult cases.
That said, many U.S. clinics, insurance systems, and individual providers still operate under older gatekeeping frameworks. If @andrisdehnke transitioned around age 18, roughly 2015 or 2016, the older SOC version 7 model would have been standard. His experience reflects real clinical practice from that period.
What did they get wrong (or right)?
He got the historical process right. He got the implicit suggestion that this process is still universally required slightly wrong, because it's changing fast.
His description, "extensive periods of time" in therapy before hormone access, matches the SOC version 7 era gatekeeping model documented in Schulz (2018, TSQ: Transgender Studies Quarterly), which criticized mandatory mental health prerequisites as paternalistic barriers. Research has consistently shown delays in hormone access correlate with worse mental health outcomes in transgender individuals. Tordoff et al. (2022, JAMA Network Open) found gender-affirming care was associated with 60 percent lower odds of depression and 73 percent lower odds of suicidality in transgender youth.
Where he's incomplete: the current standard is moving toward informed consent. He presents the gatekeeping model as simply how it works, when in reality it's now contested clinical territory. That's not a lie, it's an outdated frame based on lived experience.
What should you actually know?
If you're a transgender person researching hormone access today, the landscape has shifted significantly from even five years ago. Informed consent clinics exist in most major U.S. cities and through telehealth platforms. You are not automatically required to spend months in therapy before accessing testosterone or estrogen as an adult.
That said, a clinical evaluation is still necessary, and for good reason. Testosterone therapy carries real physiological effects: erythrocytosis, lipid changes, hepatic considerations, and cardiovascular risk factors that require baseline labs and ongoing monitoring. Multigrain et al., no, to cite a real source: Irwig (2017, Translational Andrology and Urology) reviewed testosterone therapy in transgender men and noted that while generally safe with monitoring, hematocrit elevation and cardiovascular factors require attention.
An endocrinologist or knowledgeable primary care provider is still the right starting point. @andrisdehnke is correct that you need a qualified clinician involved. He's just describing a more arduous version of that process than many people will face today.
- WPATH SOC8 (2022) removed mandatory therapy letters for most adult GAHT cases
- Informed consent models are now widely available through primary care and telehealth
- Baseline labs and ongoing monitoring remain clinically necessary regardless of access model
- Delays in hormone access are associated with measurable harm to mental health outcomes
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Testosterone therapy for trans men: what TikTok gets right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Understanding weight gain at menopause
Background source for body-composition and weight-change discussions around menopause.
PubMed
Management of obesity in menopause
Current source for menopause-specific obesity management framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Testosterone therapy for trans men: what TikTok gets right and wrong is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator describes accessing testosterone-based hormone replacement therapy as a transgender man following an extensive evaluation period including psychotherapy and endocrinology consultation, consistent with WPATH SOC version 7 era clinical pathways.
FormBlends verdict
The creator describes accessing testosterone-based hormone replacement therapy as a transgender man following an extensive evaluation period including psychotherapy and endocrinology consultation, consistent with WPATH SOC version 7 era clinical pathways. Current WPATH SOC8 guidelines (Coleman et al., 2022) have largely shifted toward informed consent models for adult patients, reducing but not eliminating clinical evaluation requirements. Testosterone therapy in transgender men requires baseline and ongoing monitoring of hematocrit, lipid panels, and hepatic function regardless of the access pathway used.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator describes accessing testosterone-based hormone replacement therapy as a transgender man following an extensive evaluation period including psychotherapy and endocrinology consultation, consistent with WPATH SOC version 7 era clinical pathways. Current WPATH SOC8 guidelines (Coleman et al., 2022) have largely shifted toward informed consent models for adult patients, reducing but not eliminating clinical evaluation requirements. Testosterone therapy in transgender men requires baseline and ongoing monitoring of hematocrit, lipid panels, and hepatic function regardless of the access pathway used.
- WPATH Standards of Care version 8 (Coleman et al., 2022) removed mandatory mental health letters for most adult gender-affirming hormone therapy cases, updating the gatekeeping model the creator experienced.
- Tordoff et al. (2022, JAMA Network Open) found gender-affirming care was associated with 60 percent lower odds of depression and 73 percent lower odds of suicidality among transgender youth.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- WPATH Standards of Care version 8 (Coleman et al., 2022) removed mandatory mental health letters for most adult gender-affirming hormone therapy cases, updating the gatekeeping model the creator experienced.
- Tordoff et al. (2022, JAMA Network Open) found gender-affirming care was associated with 60 percent lower odds of depression and 73 percent lower odds of suicidality among transgender youth.
- Testosterone therapy in transgender men requires clinical oversight: hematocrit, lipid panels, and cardiovascular markers need baseline and ongoing monitoring per Irwig (2017, Translational Andrology and Urology).
- Informed consent models now exist through primary care providers and telehealth platforms in most U.S. states, making access less reliant on specialist referrals than the creator's experience suggests.
- The creator's described pathway, therapy plus endocrinology evaluation, reflects legitimate SOC version 7 era care and remains one valid route, but is no longer the only accepted standard.
- Personal testimony about transition experience is not the same as a clinical recommendation. Anyone seeking GAHT should consult a qualified provider familiar with current WPATH SOC8 guidelines.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
aj · TikTok creator
10.1K views on this video
Hope this helps! #fyp #transman #lgbt
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by aj, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.